Back to Search Start Over

PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration.

Authors :
Piao W
Li L
Saxena V
Iyyathurai J
Lakhan R
Zhang Y
Lape IT
Paluskievicz C
Hippen KL
Lee Y
Silverman E
Shirkey MW
Riella LV
Blazar BR
Bromberg JS
Source :
Nature communications [Nat Commun] 2022 Apr 21; Vol. 13 (1), pp. 2176. Date of Electronic Publication: 2022 Apr 21.
Publication Year :
2022

Abstract

Programmed death-1 (PD-1) and its ligand PD-L1 are checkpoint molecules which regulate immune responses. Little is known about their functions in T cell migration and there are contradictory data about their roles in regulatory T cell (Treg) function. Here we show activated Tregs and CD4 effector T cells (Teffs) use PD-1/PD-L1 and CD80/PD-L1, respectively, to regulate transendothelial migration across lymphatic endothelial cells (LECs). Antibody blockade of Treg PD-1, Teff CD80 (the alternative ligand for PD-L1), or LEC PD-L1 impairs Treg or Teff migration in vitro and in vivo. PD-1/PD-L1 signals through PI3K/Akt and ERK to regulate zipper junctional VE-cadherin, and through NFκB-p65 to up-regulate VCAM-1 expression on LECs. CD80/PD-L1 signaling up-regulates VCAM-1 through ERK and NFκB-p65. PD-1 and CD80 blockade reduces tumor egress of PD-1 <superscript>high</superscript> fragile Tregs and Teffs into draining lymph nodes, respectively, and promotes tumor regression. These data provide roles for PD-L1 in cell migration and immune regulation.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
2041-1723
Volume :
13
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
35449134
Full Text :
https://doi.org/10.1038/s41467-022-29930-0